FDA Inspection
Biovectra, Inc.Biovectra, Inc. – FDA Inspection, Feb 17, 2017
Record Details
This FDA Inspection record concerns Biovectra, Inc., with an inspection on February 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 414fec90-8c34-4acb-8363-3fd7049d3ec8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1008484
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Biovectra, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 19, 2024 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| August 26, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 17, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| August 25, 2010 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Biovectra, Inc.
- FDA Inspection 1239225 - 2024-04-19
- FDA Inspection 1180023 - 2022-08-26
- FDA Inspection 927704 - 2015-04-17
- FDA Inspection 847468 - 2013-08-08
- FDA Inspection 684938 - 2010-08-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.